VX-166
VX-166, a pan caspase inhibitor, can be used for the research of Non- Alcoholic Fatty Liver Disease (NAFLD), nonalcoholic steatohepatitis (NASH), alcoholic steatohepatitis (ASH), and other diseases involving fibrosis, steatosis, or inflammation of the liver[1].
Product Specifications
CAS Number
800408-39-3
UNSPSC
12352005
Target
Caspase
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vx-166.html
Smiles
FC(C(F)=CC(F)=C1F)=C1OCC([C@H](CC(O)=O)NC([C@@H](N2C(C(NC(OC)=O)=CC=C2)=O)CC)=O)=O
Molecular Formula
C22H21F4N3O8
Molecular Weight
531.41
References & Citations
[1]John Pollard, et al. Treatment of liver diseases with a caspase inhibitor. Patent WO2010120880A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
375032-01 20 µg
RELN, Recombinant, Human, aa26-254, His-Tag (Reelin)
Sign In for Pricing
View Details 
375032-02 100 µg
RELN, Recombinant, Human, aa26-254, His-Tag (Reelin)
Sign In for Pricing
View Details 
375032-03 1 mg
RELN, Recombinant, Human, aa26-254, His-Tag (Reelin)
Sign In for Pricing
View Details OM617804 96 Strip Well
Bovine canopy 4 homolog (zebrafish) ELISA Kit
Sign In for Pricing
View Details MBS1404839-01 0.02 mg (E-Coli)
Recombinant Chicken Probable RNA-binding protein EIF1AD (eif1ad)
Sign In for Pricing
View Details